{"commentary":{"count":4,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":4},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":false},"name":"ARCHER","nct_id":"NCT05950139","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=archer-nct05950139. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–12 commentary sources"},"registry":{"acronym":"ARCHER","arms":[{"description":"All patients will receive the intervention","label":"Advanced ALK+ NSCLC","type":"EXPERIMENTAL"}],"collaborators":["Oncovir, Inc."],"completion_date":{"date":"2029-07","type":"ESTIMATED"},"conditions":["NSCLC Stage IV","ALK Fusion Protein Expression"],"enrollment":{"count":12,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Peptide vaccine","type":"BIOLOGICAL"}],"last_update":"2026-07-28","lead_sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","official_title":"Pilot Study of a Prophylactic Cancer Peptide Vaccine in Advanced ALK+ NSCLC","overall_status":"RECRUITING","phases":["PHASE1","PHASE2"],"primary_completion_date":{"date":"2027-07","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Incidence of treatment-related adverse events","timeFrame":"Up to 2 years"},{"measure":"Vaccine-specific immune response","timeFrame":"Up to 2 years"}],"references":[],"start_date":{"date":"2024-05-13","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC","url":"https://clinicaltrials.gov/study/NCT05950139"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/archer-nct05950139"}